- SOALAN-SOALAN LAZIM (FAQ) BERKAITAN TUNTUTAN MATA CPD PROGRAM PERKHIDMATAN FARMASI
- Siri Panduan Infografik Berkaitan Tuntutan Mata CPD
- Permohonan Pendaftaran Sementara Ahli Farmasi dengan Lembaga Farmasi Malaysia
- Pesanan Untuk Ahli Farmasi Berdaftar
- Senarai Premis Latihan Bagi Pegawai Farmasi Provisional (PRP)
Anda di sini
Search
Dipaparkan jumlah carian 131 - 140 daripada 1546
No, the use of leadership claim of a product is prohibited. Surveys relying on unvalidated data, due to a lack of recognition by authorities, may deem the claims unjustifiable. Furthermore, making a...
Kategori: Soalan Lazim | Tarikh: 20 Feb 2024
Please refer to Registered Medicinal Product Advertising Approval Guidelines Paragraph 4.8 Comparative Advertising. Comparison of a registered health product with “Brand X” product is not possible...
Kategori: Soalan Lazim | Tarikh: 20 Feb 2024
Sila rujuk kepada Perenggan 4.8, Garis Panduan Kelulusan Pengiklanan Produk Ubat Berdaftar, perbandingan produk ubat berdaftar dengan produk "Jenama X" adalah tidak dibenarkan. Ini adalah kerana...
Kategori: Soalan Lazim | Tarikh: 20 Feb 2024
Sila rujuk kepada Perenggan 4.8, Garis Panduan Kelulusan Pengiklanan Produk Ubat Berdaftar. Pengiklanan perbandingan adalah dibenarkan untuk akuan perbandingan produk-produk keluaran syarikat yang...
Kategori: Soalan Lazim | Tarikh: 20 Feb 2024
Please refer to Registered Medicinal Product Advertising Approval Guidelines Paragraph 4.8 Comparative Advertising. Comparative advertising is allowed in the context where it is compared with their...
Kategori: Soalan Lazim | Tarikh: 20 Feb 2024
Healthcare professionals may participate in NCE press release advertisement to explain about a disease, statistics on diseases etc. However, healthcare professionals are not allowed, whether directly...
Kategori: Soalan Lazim | Tarikh: 20 Feb 2024
Profesional kesihatan dibenarkan untuk menyertai siaran akhbar produk baharu bagi menjelaskan tentang penyakit, statistik penyakit, dan sebagainya. Walau bagaimanapun, profesional kesihatan tidak...
Kategori: Soalan Lazim | Tarikh: 20 Feb 2024
Kreativiti dalam iklan produk kesihatan adalah dibenarkan dengan syarat kreativiti tersebut tidak mengelirukan orang awam, selari dengan indikasi produk yang diluluskan oleh Pihak Berkuasa Kawalan...
Kategori: Soalan Lazim | Tarikh: 20 Feb 2024
Creativity in healthcare advertisement is allowed provided that the creativity does not mislead the public, aligned with indication approved by DCA and in compliance with the guidelines and policies...
Kategori: Soalan Lazim | Tarikh: 20 Feb 2024
All characters in the product packaging are allowed to be used in the advertisement as their intended purposes.
Please refer to the Registered Medicinal Products Advertising Approval...
Kategori: Soalan Lazim | Tarikh: 20 Feb 2024